CharlesLRaisonMD

Integrative Psychiatry

Barry and Janet Lang Associate Professor of Integrative Mental Health

Dr. Raison is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
600 Highland Ave
Madison, WI 53792
Phone+1 608-263-6100

Fax+1 608-263-7263

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Psychiatry, 1991 - 1995
Washington University in St. Louis School of MedicineClass of 1991

PubMed

96 citations
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.
Charles L Raison, Gerard Sanacora, Joshua Woolley, Keith Heinzerling, Boadie W Dunlop
JAMA. 2023-09-05
362 citations
Is Depression an Inflammatory Disorder
Charles L. Raison, Andrew H. Miller
Current Psychiatry Reports. 2011-09-17
331 citations
Neuropsychiatric Adverse Effects of Interferon-α Recognition and Management
Charles L. Raison, Marina F Demetrashvili, Lucile Capuron, Andrew H. Miller
CNS Drugs. 2005-01-01

Lectures

Approaching the Great Western Divide
University of Arizona College of Medicine at the Arizona Health Sciences Center, Sequoia National Pa - 7/23/2013
25th Annual U.S. Psychiatric and Mental Health Congress
North American Center for Continuing Medical Education, LLC / CME LLC, San Diego, California - 11/8/2012

Other

Neuropsychiatric side effects associated with interferon-alfa plus ribavirin therapy: Recognition and risk factors
Raison CL, Afdhal NH
http://www.uptodate.com/contents/neuropsychiatric-side-effects-associated-with-interferon-alfa-plus-
UpToDate, Wolters Kluwer Health - 2012-03-28
Neuropsychiatric side effects associated with interferon-alfa plus ribavirin therapy: Treatment and prevention
Raison CL, Afdhal NH
http://www.uptodate.com/contents/neuropsychiatric-side-effects-associated-with-interferon-alfa-plus-
UpToDate, Wolters Kluwer Health - 2012-08-29

What Experts Say About Taking Psilocybin as an Alternative Treatment for DepressionOctober 22nd, 2024
Millions Could Qualify for Psilocybin Therapy: Study Predicts Massive Demand if FDA Approves Depression TherapySeptember 16th, 2024
Researchers Identify an Unexpected Cause Behind DepressionFebruary 26th, 2023
Join now to see all

Inflammation, Stress, And Social Behavior: Using Ecological Assessments And ModelNational Center For Complementary &Alternative Medicine2011
Mechanisms Of MeditationNational Center For Complementary &Alternative Medicine2009–2011
Neurobiological And Behavioral Effects Of Cytokine Antagonism In Major DepressionNational Institute Of Mental Health2008–2009
Cytokine-Crh Interactions In Ifn-Alfa-Induced DepressionNational Institute Of Mental Health2005–2009
Compassion Meditation As A Strategy For Reducing Depression Symptoms ANS PhysiolNational Center For Research Resources2007
Phenotyping Immune-Based DepressionNational Center For Research Resources2004–2007
Compassion MeditationNational Center For Research Resources2006
Glucocorticoid Resistance In Immune-Based DepressionNational Institute Of Mental Health2002–2006